Using the same mouse model, Meng et al. demonstrated that inhibition of the p38/MAPK-activated protein kinase 2 pathway inhibited α-SMA expression in cFB, reduced the deposition of ECM, and alleviated myocardial fibrosis. This evidence concerns the gene CFB and Myocardial fibrosis.